Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |